Working with mouse models of colon and breast cancer, researchers demonstrated that when combined with chemotherapy, the nanoparticle reduced tumor growth substantially more than chemotherapy alone
Chemoresistance or the specific resistance acquired by cells to the action of certain chemicals commonly hinders the treatment of cancer. Existing ways to address this issue revolve around using competitive inhibitors, but have limited success. Now, a research team led by Assistant Professor Edward Chow of the Cancer Science Institute of Singapore (CSI) at NUS has found that binding multiple molecules of a common leukaemia drug with nanodiamonds can neutralise chemoresistance.
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.